Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
Infection and Immunity|July 4, 2007
Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cellsRhea N Coler, Yasuyuki Goto, Lisa Bogatzki, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
The Lancet. Infectious Diseases|July 12, 2017
Innovative tools and approaches to end the transmission of Mycobacterium lepraePeter Steinmann, Steven G Reed, Fareed Mirza, et al.
Parasite Immunology|December 22, 2020
Evolution of antigen-specific immune responses in cutaneous leishmaniasis patientsAkram Miramin Mohammadi, Malcolm S Duthie, Steven G Reed, et al.
Infection and Immunity|May 24, 2005
Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigsStephen T Reece, Nicole Stride, Pamela Ovendale, et al.
Seminars in Immunology|October 28, 2018
Correlates of GLA family adjuvants' activitiesSteven G Reed, Darrick Carter, Corey Casper, et al.
Infection and Immunity|February 18, 2010
Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotesYasuyuki Goto, Darrick Carter, Jeffrey Guderian, et al.
Vaccine|April 20, 2013
Case study for a vaccine against leishmaniasisJorge Alvar, Simon L Croft, Paul Kaye, et al.
Vaccine|January 9, 2010
Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infectionShun-Ichi Sakai, Yasuhiro Takashima, Yoshitsugu Matsumoto, et al.
The American Journal of Tropical Medicine and Hygiene|May 5, 2010
Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccineRajiv Kumar, Yasuyuki Goto, Kamlesh Gidwani, et al.
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
Infection and Immunity|July 4, 2007
Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cellsRhea N Coler, Yasuyuki Goto, Lisa Bogatzki, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
The Lancet. Infectious Diseases|July 12, 2017
Innovative tools and approaches to end the transmission of Mycobacterium lepraePeter Steinmann, Steven G Reed, Fareed Mirza, et al.
Parasite Immunology|December 22, 2020
Evolution of antigen-specific immune responses in cutaneous leishmaniasis patientsAkram Miramin Mohammadi, Malcolm S Duthie, Steven G Reed, et al.
Infection and Immunity|May 24, 2005
Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigsStephen T Reece, Nicole Stride, Pamela Ovendale, et al.
Seminars in Immunology|October 28, 2018
Correlates of GLA family adjuvants' activitiesSteven G Reed, Darrick Carter, Corey Casper, et al.
Infection and Immunity|February 18, 2010
Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotesYasuyuki Goto, Darrick Carter, Jeffrey Guderian, et al.
Vaccine|April 20, 2013
Case study for a vaccine against leishmaniasisJorge Alvar, Simon L Croft, Paul Kaye, et al.
Vaccine|January 9, 2010
Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infectionShun-Ichi Sakai, Yasuhiro Takashima, Yoshitsugu Matsumoto, et al.
The American Journal of Tropical Medicine and Hygiene|May 5, 2010
Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccineRajiv Kumar, Yasuyuki Goto, Kamlesh Gidwani, et al.
Pageof 27